Form 8-K JOHNSON & JOHNSON For: Nov 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Wall Street ends down as oil prices, Treasury yields rise
Johnson & Johnson (JNJ) transition underway, UBS assesses upcoming analyst day
December 1, 2023 9:05 AM ESTUBS maintained Johnson & Johnson (NYSE: JNJ) at Buy with a $180 per share price target on Friday in its analyst day preview note.
The firm said it expects the company to reiterate its pharma guide, while its MedTech guide will at... More
